Impact of Treatments for Postmenopausal Osteoporosis (Bisphosphonates, Parathyroid Hormone, Strontium Ranelate, and Denosumab) on Bone Quality: A Systematic Review

By Gallacher S.  

Calcified Tissue International, Vol. 87, Iss. 6, 2010-12 ,pp. : 469-484

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Pharmacology of Potent New Bisphosphonates for Postmenopausal Osteoporosis

By Chapurlat Roland D.  

Treatments in Endocrinology, Vol. 4, Iss. 2, 2005-01 ,pp. : 115-125

Adis International

Access to resources Recommend Favorite

Optimizing Administration of Bisphosphonates in Women with Postmenopausal Osteoporosis

By Rackoff Paula J.   Sebba Anthony  

Treatments in Endocrinology, Vol. 4, Iss. 4, 2005-01 ,pp. : 245-251

Adis International

Access to resources Recommend Favorite

Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis

By Dane Cem   Dane Banu   Cetin Ahmet   Erginbas Murat  

Gynecological Endocrinology, Vol. 23, Iss. 7, 2007-07 ,pp. : 398-403

Informa Healthcare

Access to resources Recommend Favorite

Endocrinology. Effects of alendronate and hormone replacement therapy, alone or in combination, on bone mass in postmenopausal women with osteoporosis: a prospective, randomized study

By Tıraş M.B.   Noyan V.   Yıldız A.   Yıldırım M.  

Human Reproduction, Vol. 15, Iss. 10, 2000-10 ,pp. : 2087-2092

Oxford University Press

Access to resources Recommend Favorite